This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Chagas disease, caused by Trypanosoma cruzi, is a major cause of cardiomyopathy and stroke in South America and affects 16 to 18 million people.1 The main manifestations of cardiac disease are cardiomyopathy, congestive heart failure, arrhythmias, and thromboembolic phenomena, which can appear up to 30 years after the acute infection.
Since 1995, thrombolytic therapy has been used increasingly in acute ischemic stroke.2 However, patients with high risk of cardiac thrombus (e.g., after acute myocardial infarction) were excluded from the major multicenter studies. Additionally, rare cases of focal deficits caused by vasculitis have been described related to Chagas disease,3 which may not respond to thrombolysis. Therefore, the risk of thrombolytic therapy in Chagas disease should be better studied. We describe the first two cases of thrombolytic therapy in acute stroke caused by Chagas disease.
Case reports.
Case 1.
A 73-year-old man was admitted with sudden onset of right hemiplegia and aphasia 30 minutes before admission. …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
MRI-based thrombolytic therapy in patients with acute ischemic stroke presenting with a low NIHSS
Distal hyperintense vessels on FLAIR
Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Clinical Reasoning: Mechanical thrombectomy for acute ischemic stroke in the setting of atrial myxoma